| Symbol |
Name |
|
ARSE
|
arylsulfatase E (chondrodysplasia punctata 1)
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BRD8
|
bromodomain containing 8
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CD1D
|
CD1d molecule
|
|
CFP
|
complement factor properdin
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHKB
|
choline kinase beta
|
|
COX11
|
COX11 cytochrome c oxidase copper chaperone
|
|
CPSF4
|
cleavage and polyadenylation specific factor 4, 30kDa
|
|
CSNK1G2
|
casein kinase 1, gamma 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
DCAF7
|
DDB1 and CUL4 associated factor 7
|
|
DDX27
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27
|
|
DIDO1
|
death inducer-obliterator 1
|
|
DUSP11
|
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ERP29
|
endoplasmic reticulum protein 29
|
|
ETV5
|
ets variant 5
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GCN1L1
|
GCN1 general control of amino-acid synthesis 1-like 1 (yeast)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIST1H2AE
|
histone cluster 1, H2ae
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
KIAA0226
|
KIAA0226
|
|
KIAA0513
|
KIAA0513
|
|
KIAA0586
|
KIAA0586
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
LPIN2
|
lipin 2
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
METTL21B
|
methyltransferase like 21B
|
|
MTMR9
|
myotubularin related protein 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
PIBF1
|
progesterone immunomodulatory binding factor 1
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PREP
|
prolyl endopeptidase
|
|
PTDSS1
|
phosphatidylserine synthase 1
|
|
RALGAPA1
|
Ral GTPase activating protein, alpha subunit 1 (catalytic)
|
|
RANBP9
|
RAN binding protein 9
|
|
RBM4B
|
RNA binding motif protein 4B
|
|
S100A5
|
S100 calcium binding protein A5
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SPHAR
|
S-phase response (cyclin related)
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SRP72
|
signal recognition particle 72kDa
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
SYNJ1
|
synaptojanin 1
|
|
TBCC
|
tubulin folding cofactor C
|
|
TMEM5
|
transmembrane protein 5
|
|
TRIAP1
|
TP53 regulated inhibitor of apoptosis 1
|
|
UROS
|
uroporphyrinogen III synthase
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WBSCR22
|
Williams Beuren syndrome chromosome region 22
|